[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 50.16.52.237. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters to the Editor
March 2001

In reply

Arch Neurol. 2001;58(3):519-520. doi:

We agree with Dr Mackenzie that there is a substantial difference between patients with DLB and AD in terms of the degree of brain inflammation, as noted in his recent report.1 Patients with DLB have a much reduced inflammatory response, and, if anti-inflammatory medications target brain inflammation, patients with AD would be expected to show greater benefit than those with DLB.

First Page Preview View Large
First page PDF preview
First page PDF preview
×